Figure 5.

Therapies used in the past 12 mo (N=673). LTRA=leukotriene receptor antagonists. Other immunosuppressants included methotrexate and mycophenolate mofetil; other specified therapies included intravenous immunoglobulin, narrowband ultraviolet B procedure, dapsone, hydroxychloroquine, levamisole, mesalazine, sulfasalazine, nifedipine, stanozolol, and warfarin. Multiple H₁‐antihistamines included combinations of second‐ and/or third‐generation H₁‐antihistamine therapies, as well as patients who have multiple records of the same H₁‐antihistamine